Dr Jacob E Smith, MD in Springfield, MO - Medicare Otolaryngology

Dr Jacob E Smith, MD is a medicare enrolled "Otolaryngology" physician in Springfield, Missouri. He graduated from medical school in 2006 and has 18 years of diverse experience with area of expertise as Otolaryngology. He is a member of the group practice Lester E Cox Medical Centers and his current practice location is 960 E Walnut Lawn St, Suite 102, Springfield, Missouri. You can reach out to his office (for appointments etc.) via phone at (417) 875-3600.

Dr Jacob E Smith is licensed to practice in Missouri (license number 2011006609) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1538249016.

Contact Information

	Dr Jacob E Smith, MD
	960 E Walnut Lawn St, Suite 102, Springfield, MO 65807-7506
	(417) 875-3600
	(417) 875-3625

Physician's Profile

Full Name	Dr Jacob E Smith
Gender	Male
Speciality	Otolaryngology
Experience	18 Years
Location	960 E Walnut Lawn St, Springfield, Missouri
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Jacob E Smith graduated from medical school in 2006

NPI Data:

NPI Number: 1538249016
Provider Enumeration Date: 10/17/2006
Last Update Date: 12/27/2018

Medicare PECOS Information:

PECOS PAC ID: 1557532165
Enrollment ID: I20110912000177

Medical Identifiers

Medical identifiers for Dr Jacob E Smith such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1538249016	NPI	-	NPPES
1538249012	Medicaid	MO
206588907	Medicaid	MO

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Y00000X	Otolaryngology	2011006609 (Missouri)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Cox Medical Centers	Springfield, MO	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Lester E Cox Medical Centers	8628092897	219

News Archive

Dissolvable tobacco harmless finds FDA panel but promises detailed review

An advisory panel to the Food and Drugs Administration (FDA) said Thursday that people who exclusively use dissolvable tobacco products have a greatly reduced risk of cancer and respiratory illness compared with those who regularly smoke cigarettes.

Perrigo agrees to acquire Omega for $4.5 billion

Perrigo Company plc, a leading global provider of "Quality Affordable Healthcare Products," and Omega Pharma NV, one of the largest OTC healthcare companies in Europe, headquartered in Nazareth, Belgium, today announced that they have entered into a definitive agreement in which Perrigo has agreed to acquire Omega for €3.6 billion, or $4.5 billion, comprised of the purchase of Omega's equity for €2.48 billion and the assumption of €1.1 billion in debt.

FDA agrees to allow ADial to move forward with Phase III trial of AD04 for alcohol use disorder

ADial Pharmaceuticals, LLC, announced today that the U.S. Food and Drug Administration has agreed to allow ADial to move forward with its plan to initiate Phase III trials of AD04 as a treatment for alcohol use disorder in certain targeted genotypes population only.

Fluticasone gets rid of eosinophils in the esophagus, but does not improve symptoms

A group of Mayo Clinic researchers conducted the first controlled trial of swallowed fluticasone nasal spray (also known as Flonase) on people with the allergic esophageal condition called eosinophilic esophagitis. Research showed that the aerosolized swallowed allergy drug helped treat the cause of the throat condition, but symptoms lingered. The researchers' findings were presented today at the Annual Scientific Meeting of the American College of Gastroenterology in San Antonio.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Jacob E Smith allows following entities to bill medicare on his behalf.

Entity Name	Lester E Cox Medical Centers
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1760405864 PECOS PAC ID: 8628092897 Enrollment ID: O20060116000342

News Archive

Dissolvable tobacco harmless finds FDA panel but promises detailed review

Perrigo agrees to acquire Omega for $4.5 billion

FDA agrees to allow ADial to move forward with Phase III trial of AD04 for alcohol use disorder

Fluticasone gets rid of eosinophils in the esophagus, but does not improve symptoms

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Jacob E Smith is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Jacob E Smith, MD 960 E Walnut Lawn St, Suite 102, Springfield, MO 65807-7506 Ph: (417) 875-3600	Dr Jacob E Smith, MD 960 E Walnut Lawn St, Suite 102, Springfield, MO 65807-7506 Ph: (417) 875-3600

News Archive

Dissolvable tobacco harmless finds FDA panel but promises detailed review

Perrigo agrees to acquire Omega for $4.5 billion

FDA agrees to allow ADial to move forward with Phase III trial of AD04 for alcohol use disorder

Fluticasone gets rid of eosinophils in the esophagus, but does not improve symptoms

Otolaryngology Doctors in Springfield, MO

David Rhea Gilley, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 960 E Walnut Lawn St Ste 102, Springfield, MO 65807 Phone: 417-875-3000
Dr. Rebecca Wiley, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 960 E Walnut Lawn St Ste 102, Springfield, MO 65807 Phone: 417-875-3600
Dr. A. Daniel Pinheiro, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1229 E Seminole St, Springfield, MO 65804 Phone: 417-820-5750 Fax: 417-820-5066
Jeffrey Richard Fenwick, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 960 E Walnut Lawn St, Suite 102, Springfield, MO 65807 Phone: 417-875-3600 Fax: 417-875-3612
Anthony A Bentley, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 960 E Walnut Lawn St, Suite 102, Springfield, MO 65807 Phone: 417-875-3000 Fax: 417-875-3625
Dr. Erich Mertensmeyer, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1229 E Seminole St, Ste 520, Springfield, MO 65804 Phone: 417-820-5750 Fax: 417-820-5066
Dr. Allan L. Allphin, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1229 E Seminole St, Springfield, MO 65804 Phone: 417-820-5750 Fax: 417-820-5066

Dr Jacob E Smith, MD - Medicare Otolaryngology in Springfield, MO

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Dissolvable tobacco harmless finds FDA panel but promises detailed review

Perrigo agrees to acquire Omega for $4.5 billion

FDA agrees to allow ADial to move forward with Phase III trial of AD04 for alcohol use disorder

Fluticasone gets rid of eosinophils in the esophagus, but does not improve symptoms

Medicare Reassignments

Dissolvable tobacco harmless finds FDA panel but promises detailed review

Perrigo agrees to acquire Omega for $4.5 billion

FDA agrees to allow ADial to move forward with Phase III trial of AD04 for alcohol use disorder

Fluticasone gets rid of eosinophils in the esophagus, but does not improve symptoms

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Dissolvable tobacco harmless finds FDA panel but promises detailed review

Perrigo agrees to acquire Omega for $4.5 billion

FDA agrees to allow ADial to move forward with Phase III trial of AD04 for alcohol use disorder

Fluticasone gets rid of eosinophils in the esophagus, but does not improve symptoms

Otolaryngology Doctors in Springfield, MO